FindTrial
Sign In

Study to evaluate the effect of arterial embolization prior to surgery on intraoperative blood loss during resection of hypervascularized soft tissue sarcoma (TEAM HYPER-VASC)

Study to evaluate the effect of arterial embolization prior to surgery on intraoperative blood loss during resection of hypervascularized soft tissue sarcoma (TEAM HYPER-VASC) - TEAM HYPER-VASC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025460
Enrollment
24
Registered
2021-06-01
Start date
2021-06-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49.2 C49.1

Interventions

Group 1: arterial embolization prior to surgery of hypervascularized soft tissue sarcoma Group 2: surgery of hypervascularized soft tissue sarcoma without arterial embolization

Sponsors

Klinik für Unfall-, Hand- und Wiederherstellungschirurgie Universitätsklinikum Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - histologic diagnosed soft tissue sarcoma of extremity or torso - hypervascularsation of the sarcoma - age = 18y - written consent - sui juris - compliance

Exclusion criteria

Exclusion criteria: - age < 18y - non compose mentis declared by court or public authorities - inclusion in another clinical trial - inoperative local tumor - contraindication on MRI or MRI-angiography - coagulation disease that contradicts arterial punction - severe atheromatosis - for embolisation improperly vascular morphology - pregnancy

Design outcomes

Primary

MeasureTime frame
intra-and postoperative blood loss in resection of soft tissue sarcoma—

Secondary

MeasureTime frame
- quantity of intraoperative blood loss (ml) - quantity of postoperative blood loss by drainage 48h postoperative (ml) - amount of intra- and postoperative transfused blood products (ml) - operative duration (min) - R-status - local control - metastasis-free survival 24 month after resection—

Countries

Germany

Contacts

Public ContactMatthias Vogt

Klinik für Unfall-, Hand- und Wiederherstellungschirurgie Universitätsklinikum Jena

matthias.vogt@med.uni-jena.de03641-9322801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026